Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed Start vs Conventional Antagonist Protocol in Poor Responders
NCT02333253Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetrorelix in female infertility, sponsored by Cairo University. Started Jan 2015; status: completed.
02
Drugs
cetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT02333253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333253.